Evidence map›Paper›PMID 38542455›Full record

ArticleInternational journal of molecular sciences2024

Anne Linde Mak, Quinten J J Augustijn, Clément J F Heymann, Stefan Havik, Xanthe Verdoes, Melany Rios-Morales, Laura A Bosmans, Joanne Verheij, Abraham S Meijnikman, Patrick A de Jonge and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. IntestinalInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Anne Linde MakDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-2101-161X
Quinten J J AugustijnDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Clément J F HeymannDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Stefan HavikDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Xanthe VerdoesDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Melany Rios-MoralesDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Laura A BosmansDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Joanne VerheijDepartment of Pathology, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0003-1283-630X
Abraham S MeijnikmanDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Patrick A de JongeDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0003-2980-8444
Hilde HerremaDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Willem M de VosCaelus Health, 1105 BP Amsterdam, The Netherlands.ORCID 0000-0002-0273-3166
Max NieuwdorpDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Aldo GrefhorstDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Adriaan G HolleboomDepartment of (Experimental) Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a growing health problem for which no therapy exists to date. The modulation of the gut microbiome may have treatment potential for MASLD. Here, we investigated

Indexed as

EubacterialesFatty LiverMetabolic DiseasesAnimalsBase CompositionButyratesGene ExpressionGluconeogenesisMaleMiceMice, Inbred C57BLPhosphatidate PhosphatasePhylogenyRNA, Ribosomal, 16SSequence Analysis, DNAButyratesLpin1 protein, mousePhosphatidate PhosphataseRNA, Ribosomal, 16Sgut microbiomeMASLDmiceshort-chain fatty acids

Identifiers

PMID38542455
PMCPMC10970496
OpenAlexW4393007050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.